logo

For the Inventor, By the Inventor

Heidelberg, Germany

Wilfried Lubisch

USPTO Granted Patents = 83 

 

 

Average Co-Inventor Count = 4.8

ph-index = 15

Forward Citations = 524(Granted Patents)

Forward Citations (Not Self Cited) = 441(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Mannheim, DE (1990 - 2002)
  • Heldelberg, DE (2014)
  • Neckargemuend, DE (2011 - 2015)
  • Heidelberg, DE (2002 - 2016)
  • Ludwigshafen, DE (2013 - 2016)

Company Filing History:

goldMedal31 out of 139 
 
Abbott Gmbh & Co Kg
 patents
silverMedal25 out of 10,754 
 
Basf Aktiengesellschaft
 patents
bronzeMedal15 out of 167 
 
Abbvie Deutschland Gmbh and Co Kg
 patents
4. 11 out of 4,179 
 
Abbott Laboratories Corporation
 patents
5. 1 out of 1 
 
Abbott Gmbh & Co. Hg
 patent
6. 1 out of 832,843 
Other
 patents
where one patent can have more than one assignee

Years Active: 1990-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Oxindole Derivatives
Vasopressin Receptor Ligands
Calpain Inhibitors
Poly(ADP-Ribose) Polymerase
Dopamine D3 Receptor
Heteroaryl Compounds
Benzimidazolone Derivatives
Pyrimidine Compounds
Substituted Amides
Keto Lactam Compounds
Dibenzodiazepine Derivatives
Heterocyclic Compounds
83 patents (USPTO):Explore Patents
1. 9487505 - Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them (2016-11-08),
2. 9434713 - 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases (2016-09-06),
3. 9422264 - Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases (2016-08-23),
4. 9403796 - Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses (2016-08-02),
5. 9238642 - Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses (2016-01-19),
6. 9139557 - Carboxamide compounds and their use as calpain inhibitors (2015-09-22),
7. 9051553 - Poly(ADP-ribose) polymerase genes (2015-06-09),
8. 9023854 - 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases (2015-05-05),
9. 9006276 - Substituted oxindole derivatives, medicaments containing said derivatives and use thereof (2015-04-14),
10. 8859557 - Substituted oxindole derivatives and their use as vasopressin receptor ligands (2014-10-14),
11. 8815868 - Substituted oxindole derivatives and their use as vasopressin receptor ligands (2014-08-26),
12. 8791148 - Substituted benzimidazolone derivatives, medicaments comprising them and their use (2014-07-29),
13. 8703775 - Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses (2014-04-22),
14. 8703774 - Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases (2014-04-22),
15. 8691815 - Substituted oxindole derivatives, drugs containing said derivatives and the use thereof (2014-04-08),

Title: Spotlight on Inventor Wilfried Lubisch from Heidelberg, DE

Introduction

Wilfried Lubisch is a prolific inventor based in Heidelberg, Germany, with an impressive portfolio of 83 patents to his name. His innovative spirit and dedication to advancing pharmaceutical developments have positioned him as a key figure in the field of medicinal chemistry.

Latest Patents

Among his latest patents is the groundbreaking work on Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them. This invention introduces novel 1,3-dihydroindol-2-one derivatives that show promise in treating vasopressin-dependent diseases, offering hope for patients facing such challenging conditions.

Career Highlights

Wilfried Lubisch's professional journey has seen him collaborate with renowned companies such as Abbott GmbH & Co. KG and BASF Aktiengesellschaft. His contributions to these organizations have been instrumental in driving innovation and fostering growth in the pharmaceutical industry, solidifying his reputation as a forward-thinker in the field.

Collaborations

Throughout his career, Wilfried Lubisch has worked alongside esteemed colleagues such as Liliane Unger and Wilfried Hornberger. These collaborative efforts have led to the development of cutting-edge technologies and the creation of impactful solutions that have the potential to transform healthcare practices worldwide.

Conclusion

Inventor Wilfried Lubisch's dedication to pushing the boundaries of medicinal chemistry and his relentless pursuit of innovative solutions underscore his status as a visionary in the field of pharmaceutical research. His patents, collaborations, and career highlights stand as a testament to his unwavering commitment to driving progress and making a meaningful impact in the world of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…